According to some on this board failing Sunrise was a good thing because we will get to market sooner, R/S split doesn't hurt shareholders although we do need send a letter of warning to those who are supposed to be protecting shareholders, we are filing a BLA for Bavi to be used in conjunction with chemo even though all chemo trials have been halted, I/O combo trials have been secretly running in the background, and PPHM is connected to every single person who works for a BP anywhere in the world. I think that pretty much sums up the bull case.
<disclosure> with my recent buy at $0.37 I now own more shares than ever before.
Market Data 
Markets 
AI
